Literature DB >> 20120753

Emerging cutaneous leishmaniasis in Sirte-Libya: epidemiology, recognition and management.

Fouad M Fathy1, Fathi El-Kasah, Abdulla M El-Ahwal.   

Abstract

The present work aimed to determine the risk factors, lesion pattern and effective therapy of emerging ZCL in Sirte-Libya. The study was carried out on 163 patients referred to health centers of Al-Gadaheya and Al-Hisha villages in the years 2006 & 2007. Methods consisted of a predesigned questionnaire (personal and demographic data), clinical examination of lesions, and parasitological examination by slit smear, treatment and follow up. Results showed an annual incidence of 0.95%, with onset peak during autumn months. Important local risk factors included: increased occupational exposure of farmers and construction worker to infection from fat sand rat burrows, facilitated by lack of prevention knowledge and prophylactic measures; close association of bad-ventilated animal shelters to houses, and increased soil moisture by warm spring ponds. The majority of lesions were multiple (73%) located on legs, arms, and face 66.8%, 52.1% and 41.1%. Most lesions were active 1-2 month duration and 1-3 cm size, ulcerative type (77.3%), and papulo-nodular (21.5%). Giemsa slit smear proved quite reliable for active lesions, confirmed 79.5% of lesions. The majority of lesions (60.1%) were treated by intra-lesional Pentostam. Systemic route was restricted to facial, over-joint, multiple or large lesions producing, good response in 31.9%. Cryotherapy and oral Fluconazole gave satisfactory response in 5.5% & 2.5% of cases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20120753

Source DB:  PubMed          Journal:  J Egypt Soc Parasitol        ISSN: 1110-0583


  9 in total

1.  Joint spatial time-series epidemiological analysis of malaria and cutaneous leishmaniasis infection.

Authors:  O A Adegboye; M Al-Saghir; D H Y Leung
Journal:  Epidemiol Infect       Date:  2016-12-01       Impact factor: 4.434

Review 2.  Neglected tropical diseases of the Middle East and North Africa: review of their prevalence, distribution, and opportunities for control.

Authors:  Peter J Hotez; Lorenzo Savioli; Alan Fenwick
Journal:  PLoS Negl Trop Dis       Date:  2012-02-28

3.  Ecological Niche Modeling for the Prediction of the Geographic Distribution of Cutaneous Leishmaniasis in Tunisia.

Authors:  Bilel Chalghaf; Sadok Chlif; Benjamin Mayala; Wissem Ghawar; Jihène Bettaieb; Myriam Harrabi; Goze Bertin Benie; Edwin Michael; Afif Ben Salah
Journal:  Am J Trop Med Hyg       Date:  2016-02-08       Impact factor: 2.345

Review 4.  Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.

Authors:  Nayara Castelano Brito; Ana Rabello; Gláucia Fernandes Cota
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

Review 5.  Review of Leishmaniasis in the Middle East and North Africa.

Authors:  Ahmed Tabbabi
Journal:  Afr Health Sci       Date:  2019-03       Impact factor: 0.927

6.  Epidemiological profile of cutaneous leishmaniasis: retrospective analysis of 7444 cases reported from 1999 to 2005 at Ouagadougou, Burkina Faso.

Authors:  Sanata Bamba; Alphonse Gouba; Maxime Koiné Drabo; Désiré Nezien; Mamadou Bougoum; Tinga Robert Guiguemdé
Journal:  Pan Afr Med J       Date:  2013-03-19

Review 7.  Cutaneous leishmaniasis in North Africa: a review.

Authors:  Karim Aoun; Aïda Bouratbine
Journal:  Parasite       Date:  2014-03-14       Impact factor: 3.000

8.  Old World Cutaneous Leishmaniasis and Refugee Crises in the Middle East and North Africa.

Authors:  Rebecca Du; Peter J Hotez; Waleed S Al-Salem; Alvaro Acosta-Serrano
Journal:  PLoS Negl Trop Dis       Date:  2016-05-26

9.  Spatiotemporal and molecular epidemiology of cutaneous leishmaniasis in Libya.

Authors:  Ahmad Amro; Hamida Al-Dwibe; Aisha Gashout; Olga Moskalenko; Marlena Galafin; Omar Hamarsheh; Marcus Frohme; Anja Jaeschke; Gabriele Schönian; Katrin Kuhls
Journal:  PLoS Negl Trop Dis       Date:  2017-09-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.